Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Device Daily Bulletin
> New Device Will Advance Cancer Treatment
FDAnews Device Daily Bulletin
June 29, 2012
| Vol. 9 No. 128
New Device Will Advance Cancer Treatment
The future of prostate cancer therapy may lie in a tiny, “sticky” silicon chip dubbed GEDI (Geometrically Enhanced Differential Immunocapture) that can identify and collect cancer cells from a patient’s bloodstream.
Medical Xpress
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Health Affects Benefits of Implanted Heart Device
Trove of Medical Devices Found to Have Password Problems
Delcath Faces Investor Ire Following Negative FDA Panel Vote
Boston Scientific Begins Patient Enrollment in U.S. Clinical Trial for Use of Vercise DBS System for Parkinson's Disease